First National Trust Co reduced its stake in shares of Danaher Co. (NYSE:DHR) by 5.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 3,611 shares of the conglomerate’s stock after selling 190 shares during the quarter. First National Trust Co’s holdings in Danaher were worth $522,000 as of its most recent filing with the SEC.
Other hedge funds also recently bought and sold shares of the company. Howe & Rusling Inc. increased its position in Danaher by 116.3% during the third quarter. Howe & Rusling Inc. now owns 186 shares of the conglomerate’s stock worth $27,000 after acquiring an additional 100 shares during the period. Next Capital Management LLC bought a new position in Danaher during the second quarter worth $31,000. Litman Gregory Asset Management LLC bought a new position in Danaher during the second quarter worth $33,000. Altshuler Shaham Ltd increased its position in Danaher by 59.3% during the second quarter. Altshuler Shaham Ltd now owns 239 shares of the conglomerate’s stock worth $34,000 after acquiring an additional 89 shares during the period. Finally, Pinnacle Bank increased its position in Danaher by 52.3% during the third quarter. Pinnacle Bank now owns 262 shares of the conglomerate’s stock worth $38,000 after acquiring an additional 90 shares during the period. Institutional investors and hedge funds own 78.30% of the company’s stock.
NYSE DHR traded up $0.16 during trading hours on Thursday, hitting $135.02. 6,250 shares of the company were exchanged, compared to its average volume of 2,066,815. The stock has a 50-day moving average price of $139.47 and a 200 day moving average price of $138.20. The company has a quick ratio of 3.09, a current ratio of 3.43 and a debt-to-equity ratio of 0.52. Danaher Co. has a 52 week low of $94.59 and a 52 week high of $147.33. The stock has a market cap of $97.13 billion, a PE ratio of 29.83, a price-to-earnings-growth ratio of 2.27 and a beta of 0.92.
Danaher (NYSE:DHR) last issued its quarterly earnings data on Thursday, October 24th. The conglomerate reported $1.16 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.15 by $0.01. The company had revenue of $5.04 billion for the quarter, compared to analysts’ expectations of $5.02 billion. Danaher had a return on equity of 11.42% and a net margin of 12.13%. The firm’s revenue for the quarter was up 3.8% on a year-over-year basis. During the same period in the previous year, the firm posted $1.10 earnings per share. As a group, sell-side analysts anticipate that Danaher Co. will post 4.76 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were issued a dividend of $0.17 per share. The ex-dividend date was Thursday, September 26th. This represents a $0.68 annualized dividend and a dividend yield of 0.50%. Danaher’s dividend payout ratio is presently 15.04%.
In other news, Chairman Mitchell P. Rales bought 2,500 shares of the business’s stock in a transaction that occurred on Friday, August 23rd. The shares were purchased at an average cost of $139.52 per share, with a total value of $348,800.00. Following the transaction, the chairman now directly owns 3,030,453 shares in the company, valued at $422,808,802.56. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 11.40% of the stock is owned by corporate insiders.
Several equities research analysts have issued reports on the stock. Argus boosted their price target on shares of Danaher to $165.00 and gave the company a “buy” rating in a report on Tuesday, July 23rd. ValuEngine lowered shares of Danaher from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Needham & Company LLC lowered their price target on shares of Danaher from $155.00 to $152.00 and set a “buy” rating on the stock in a report on Monday, October 28th. Piper Jaffray Companies boosted their price target on shares of Danaher from $148.00 to $153.00 and gave the company a “neutral” rating in a report on Thursday, July 18th. Finally, Robert W. Baird boosted their price target on shares of Danaher from $131.00 to $148.00 and gave the company an “outperform” rating in a report on Friday, July 19th. Four analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. Danaher currently has a consensus rating of “Buy” and a consensus target price of $145.86.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Further Reading: Most Active Stocks
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.